3A Comparison between R-THP-COP and R-CHOP Regimens for the Treatment of Diffuse Large B-cell Lymphoma in Old Patients: A Single-institution Analysis

OBJECTIVE: We retrospectively compared the clinical efficacy and toxicity of rituximab (R)-THP-COP (pirarubicin, cyclophosphamide, vincristine, and prednisolone) with that of R-CHOP (rituximab, adriamicin, cyclophosphamide, vincristine, and prednisolone) in previously untreated old patients with dif...

Descripción completa

Detalles Bibliográficos
Autores principales: Araie, Hiroaki, Sakamaki, Ippei, Matsuda, Yasufumi, Tai, Katsunori, Ikegaya, Satoshi, Itoh, Kazuhiro, Kishi, Shinji, Oiwa, Kana, Okura, Miyuki, Tasaki, Toshiki, Hosono, Naoko, Ueda, Takanori, Yamauchi, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643166/
https://www.ncbi.nlm.nih.gov/pubmed/28824057
http://dx.doi.org/10.2169/internalmedicine.8291-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643166/
https://www.ncbi.nlm.nih.gov/pubmed/28824057
http://dx.doi.org/10.2169/internalmedicine.8291-16

Ejemplares similares